Steven H Rouhandeh's Net Worth
-$49.7 Million
Who is Steven H Rouhandeh?
Steven H Rouhandeh does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ABEONA THERAPEUTICS INC., ENHANCE BIOTECH INC, Somanta Pharmaceuticals Inc., MACROCHEM CORP, and BIOENVISION INC.
SEC CIK
Steven H Rouhandeh's CIK is 0001294343
Past Insider Trading and Trends
2008 was Steven H Rouhandeh's most active year for acquiring shares with 35 total transactions. Steven H Rouhandeh's most active month to acquire stocks was the month of November. 2008 was Steven H Rouhandeh's most active year for disposing of shares, totalling 14 transactions. Steven H Rouhandeh's most active month to dispose stocks was the month of October. 2014 saw Steven H Rouhandeh paying a total of $108,485,192.00 for 31,250,048 shares, this is the most they've acquired in one year. In 2007 Steven H Rouhandeh cashed out on 10,325,052 shares for a total of $10,600,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ABEONA THERAPEUTICS INC. (ABEO) Snapshot price: $4.81
Executive Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +7.80% | 38.59K |
—
|
—
| 533.59K |
May 25
| |||
Form 4
| -0.72% | -80.00K |
$2.01 | -$160,888.00 | 11.08M |
Scheduled
|
May 3
| ||
Form 4
| -0.71% | -80.00K |
$2.23 | -$178,624.00 | 11.16M |
Scheduled
|
Mar 18
| ||
Form 4
| -1.06% | -120.00K |
$2.97 | -$356,808.00 | 11.24M |
Scheduled
|
Feb 16
| ||
Form 4
| -2.07% | -240.00K |
$3.01 | -$722,832.00 | 11.36M |
Scheduled
|
Feb 8
| ||
Form 4
| -2.68% | -320.00K |
$2.06 | -$658,516.23 | 11.6M |
Scheduled
|
Jan 14 - Jan 19
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 20
| |||
Form 4
| -0.02% | -1.99K |
$2.00 | -$3,981.38 | 11.92M |
Scheduled
|
Sep 15
| ||
Form 4
| -0.65% | -78.01K |
$2.07 | -$161,725.69 | 11.92M |
Scheduled
|
Sep 10 - Sep 11
| ||
Form 4
| -0.66% | -80.00K |
$2.85 | -$228,312.00 | 12M |
Scheduled
|
Aug 17
| ||
Form 4
| +32.00% | 120K |
—
|
—
| 495K |
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4/A
|
∞
| 375K |
—
|
—
| 375K |
May 11
| |||
Form 4
|
∞
| 375K |
$7.34 | $2,752,500.00 | 375K |
May 11
| |||
Form 4/A
| +19,535.85% | 13.38M |
$4.00 | $53,500,096.00 | 13.44M |
Dec 24
| |||
Form 4
| +19,207.05% | 13.38M |
$4.00 | $53,500,096.00 | 13.44M |
Dec 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 25
| |||
Form 4
| +89.82% | 1.64M |
—
|
—
| 3.46M |
Feb 26
| |||
Form 4/A
|
∞
| 901.58K |
—
|
—
| 901.58K |
Jan 4
| |||
Form 4
| +116.29% | 916.17K |
—
|
—
| 1.7M |
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 10
| |||
Form 4
|
∞
| 822.14K |
—
|
—
| 822.14K |
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 24
| |||
No matching records found |
ENHANCE BIOTECH INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Somanta Pharmaceuticals Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -8.25M |
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
MACROCHEM CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
| 23.42M |
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 18 - Jun 12
| |||
Form 4
| +260.35% | 17.88M |
—
|
—
| 24.74M |
Apr 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 18
| |||
Form 4
| +664.99% | 6.83M |
$0.60 | $4,099,835.40 | 7.86M |
Oct 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BIOENVISION INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.25% | 688.33K |
$1.50 | $1,032,499.50 | 6.81M |
May 1
| |||
Form 4
| +24.00% | 1.23M |
$3.38 | $4.43 | 6.35M |
Nov 1
| |||
No matching records found |